Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital
29/12/2023 14:46
Dec 29 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* SUBSCRIPTION OF INCREASED REGISTERED CAPITAL IN
* CRMI HEALTH SHALL MAKE CAPITAL CONTRIBUTION OF RMB10.3
MILLION
* UPON COMPLETION, CHANGZHOU BOMEI BIOTECHNOLOGY CO WILL BE
HELD
AS TO 33.3% BY CRMI HEALTH
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital